Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Raymond March
91 POSTS
0 COMMENTS
Raymond J. March
is a Research Fellow at the Independent Institute and Assistant Professor of Economics at North Dakota State University.
All Blog Posts
|
Full bio and publications
Favor Local Action to Combat the Coronavirus
Raymond March
-
March 19, 2020
0
FDA Acknowledges Coronavirus Is Causing More Drug Shortages
Raymond March
-
March 6, 2020
0
FDA’s Approval of Generic Daraprim Offers Lessons on Drugs Prices
Raymond March
-
March 5, 2020
0
Who Should Regulate Tobacco Products? Less Is More!
Raymond March
-
February 27, 2020
0
FDA Expands Ecstasy Access to Veterans with PTSD
Raymond March
-
February 12, 2020
0
Politicians Still Misunderstand High Insulin Prices
Raymond March
-
February 5, 2020
0
Are More Vaping Bans Coming Soon? Let’s Hope Not!
Raymond March
-
January 21, 2020
0
Will FDA Approve Biogen’s Promising New Treatment for Alzheimer’s?
Raymond March
-
January 16, 2020
0
Only Markets Can Alleviate Drug Shortages
Raymond March
-
December 3, 2019
0
New FDA Commissioner, Same FDA Problem
Raymond March
-
November 25, 2019
0
1
...
3
4
5
...
10
Page 4 of 10
